Regulatory GuideNovember 2, 2026 · 14 min read · VEMERIX

Does a South African Establishment Licence Cover the Proposed Device Activity?

Match the proposed activity to the licence, route the change, and check the evidence needed before adding a sterile consumable line.

South Africa RegulatorySAHPRA LicensingDistributor EnablementSupplier Qualification
Four-step Regulatory Guide diagram showing SAHPRA medical device establishment licence verification across activity scope, change routing, ISO 13485 phase readiness, and product authorization boundaries.

This guide is for distributors, importers and supplier-quality teams deciding whether a proposed activity or product addition fits an existing South African medical device establishment licence. Its worksheet supports an evidence handoff between the local licensee and overseas supplier. It does not assign a South African class to a named product or decide whether a particular tender accepts that product.

Source review: 2 November 2026. The route rules below are drawn from the live SAHPRA licensing FAQ and its May 2025 version 4 Q&A. The ISO overlay uses the later written September 2025 communication. Check the regulator’s current communications and application forms before submitting; approval of a commercial plan cannot be inferred from a table.1245

Which activities does each licence type permit?

SAHPRA licenses medical device establishments under section 22C of the Medicines and Related Substances Act. The first question is what the South African entity will actually do: import, distribute, wholesale, or perform activities regarded as manufacturing. A sales agreement calling a company a “distributor” does not establish that it holds the relevant licence.23

Licence and application formActivities described by SAHPRABuyer check
Manufacturer — GLF-MD-06AManufacture, including packaging, labelling, servicing or refurbishment; also import, distribution and exportMatch the proposed operations and site to the issued licence. A manufacturer licence encompasses distributor activities.
Distributor — GLF-MD-06CImport, export and distributeUse an appropriately scoped licence for direct importing; assess separately any proposed packaging, labelling or servicing.
Wholesaler — GLF-MD-06BProcure from local manufacturers/distributors and sell to retailers; may store for an approved manufacturer/distributorNo independent import or export authority. See the FAQ’s export-on-behalf qualification below; a storage contract does not grant importing permission.
Activity check before choosing a filing route

Source: SAHPRA licensing Q&A version 4, sections 3.1.2–3.1.3 and 3.1.19; licensing FAQ (sources 1 and 2).

For example, a wholesaler may buy from a licensed local distributor and supply domestic customers. If it instead proposes buying directly from an overseas factory and importing the goods itself, the activity changes. A new distributor licence application is needed for that proposed distributor activity; a product-list notification cannot convert the existing wholesaler licence.12

The live FAQ also says a wholesaler may store and export devices on behalf of an approved distributor or manufacturer; Q&A section 3.1.3 expressly mentions storage and otherwise prohibits wholesaler importing or exporting. Confirm the specific export-on-behalf arrangement with SAHPRA. That qualification does not give a wholesaler independent import or export authority.12

Third-party storage is a separate check. The Q&A says manufacturers and distributors using third-party storage must ensure that the storage company holds an approved establishment licence. Obtain the third party’s licence and match its scope to the contracted work. SAHPRA also issued an outsourced-activities communication in April 2026; obtain that current document when defining the arrangement. Its landing-page summary alone does not establish a universal amendment route or fee for every outsourcing contract.29

Record the Authorised Representative responsible for the filing. SAHPRA requires a natural person based in South Africa, and the Q&A defines the role in terms of residence, regulatory responsibility and company representation. A change of representative is an amendment trigger. The supplier’s foreign regulatory contact does not replace this local appointment.123

Is the change a notification, amendment or new application?

The dividing line is whether the change affects particulars of the issued licence. The live FAQ treats original-manufacturer or supplier details, GMDN codes, product names/families and same-class product additions as notification examples. A new class, changed address, representative, named personnel or licensed activities belongs in the amendment assessment. SAHPRA’s January 2026 document pages identify separate communications for product-list updates and licence amendments.1278

Read the following worksheet as a sequence: establish the activity and South African class, compare them with the issued licence, then choose the submission route. Its fee descriptions identify categories, rather than quote a current invoice. The ISO checks apply to manufacturers and distributors/importers; the wholesaler position is explained separately below.124

Add a device in a class already covered

  • Route and source clause: Product-list notification; Q&A 3.1.11–3.1.122
  • Fee consequence: No notification fee in May 2025 schedule; check current terms2
  • ISO 13485 evidence check: Phase 4 submission rule from 1 June 2027; SAHPRA may request evidence earlier4
  • Boundary to retain: Still requires review and a written outcome; not product registration.12

Add a class absent from the licence

  • Route and source clause: Amendment; Q&A 3.1.112
  • Fee consequence: Amendment application fee2
  • ISO 13485 evidence check: Check current request; Phase 4 explicitly covers amendments from 1 June 20274
  • Boundary to retain: Do not assume the missing class is covered while the amendment is pending.12

Wholesaler proposes direct importing

  • Route and source clause: New distributor application for the importing activity; Q&A 3.1.3, 3.1.182
  • Fee consequence: New application, issuing and ongoing retention charges are distinct2
  • ISO 13485 evidence check: Check new-applicant requirements; Phase 5 applies from 1 April 20284
  • Boundary to retain: A pending application does not convert the wholesaler licence.12

Replace AR or change licence particulars

  • Route and source clause: Amendment; Q&A 3.1.11, 3.1.142
  • Fee consequence: Amendment application fee2
  • ISO 13485 evidence check: Update the supporting records; apply current certificate/request rules4
  • Boundary to retain: Appointment records alone do not update the issued licence.12

Change warehouse address or outsource storage

  • Route and source clause: Address change: amendment under 3.1.11. For outsourcing, verify third-party licence under 3.1.3 and obtain current MD02 guidance2
  • Fee consequence: Determine from actual changed particulars; do not assume outsourcing is free2
  • ISO 13485 evidence check: Reconcile relevant site details with certificate coverage4
  • Boundary to retain: Your licence does not substitute for the third party’s licence.12

Product update near renewal

  • Route and source clause: Notifications may accompany renewal; amendments must wait until renewal is completed; Q&A 3.2.42
  • Fee consequence: Renewal fee; separate amendment charge if needed2
  • ISO 13485 evidence check: Phase 2 renewal evidence applies; do not use Phase 4 as a delay4
  • Boundary to retain: A renewal does not silently add an unapproved class or activity.12

Fee basis: the May 2025 Q&A lists R5 500 for an amendment and R0 for a notification. It separately lists renewal application fees of R22 900 for a manufacturer and R13 100 for a distributor or wholesaler; R4 400 is annual retention, not the renewal application fee. These are dated reference figures, not confirmed November 2026 payable amounts. Section 3.3 requires applicants to use the current Government Gazette fee structure. Do not multiply an amendment fee “per class” without an applicable fee basis.2

A notification package should preserve the approved products in the updated list and identify additions or removals. The Q&A requires a cover letter signed and dated by the AR, the application in Excel and PDF formats, a licence copy and declarations that the changes do not alter the approved class or issued-licence particulars. Keep the written outcome with the product-list revision used for commercial planning.2

An amendment requires the updated application form and supporting documents for the changed particulars, including the cover letter, quality manual or Site Master File, payment evidence, AR information, retention-payment evidence and current licence as applicable. Do not send a product brochure as if it replaces the establishment application. The FAQ also identifies adding or removing COVID-19 or Mpox kit products as amendments; do not generalize the same-class shortcut to those exceptions.12

Check filing sequence before setting a launch date. Q&A section 3.1.15 requires an amendment already in process to be finalized before another is submitted; the live FAQ states the restriction more broadly for amendments, notifications and renewals while another application is open. Section 3.2.4 and the FAQ allow notification changes within a renewal but require amendment changes to follow completion and issue of the renewed licence. That is different from running separate filings concurrently. If an AR change or new class is urgent near expiry, ask the Medical Device Unit how to sequence the specific filings.12

How should the buyer establish the device class?

The South African class is an input to the routing decision, not an output of the supplier’s sales description. Q&A section 3.1.21 directs applicants to SAHPRA’s classification guideline. Record the exact device, intended purpose, configuration and classification rationale used by the local applicant before comparing it with the licence.2

Use a conditional example. If a device’s established South African class is already on the licence and the addition changes no issued particulars, a notification may be appropriate. If that established class is missing, an amendment is required. This guide does not classify a circumcision stapler, an NPWT system or another named product. A Chinese registration class cannot simply be copied into the South African list.12

Sterility creates another boundary. SAHPRA’s operational page exempts establishments handling non-sterile, non-measuring Class A devices from licensing. All those conditions matter. A sterile device does not meet that stated exemption condition, even before deciding its risk class. Do not describe all Class A products or all disposable products as exempt. The FAQ also says licensing exemption does not itself remove the ISO 13485 requirement.13

Which ISO 13485 evidence attaches to the route?

Use MD01-2025/2026 version 2, signed 18 September 2025, rather than the older April text or a webinar summary. The written revision fixes the submission dates and describes how applicants still obtaining certification must document their agreement with a SAHPRA-recognised conformity assessment body (CAB). Holding evidence, submitting it and SAHPRA verifying it are related but different steps.4

PhaseTimingApplication consequence
2 — renewalsFrom 1 June 2025Provide the certificate for the South African establishment and address. If still obtaining it, provide documentary proof of the agreement with a recognised CAB, then submit the acquired certificate.
3 — existing certificate holdersFrom 1 April 2026Existing holders with valid certificates and no new/renewal/amendment filing are requested to submit them for verification; the live hub describes voluntary submission.
4 — amendments and notificationsFrom 1 June 2027Certificate evidence applies at the application/review stage, including product-list notifications. The written communication also provides for documented CAB agreements while certification is in process.
5 — new applicationsFrom 1 April 2028The body explicitly addresses new manufacturer/distributor applications; Annexure B describes all establishment-licence applications. Document certification or an agreement with a recognised CAB as specified.
Written ISO 13485 submission timetable for manufacturers and distributors/importers

Source: SAHPRA ISO 13485 communication version 2, Phases 2–5 and Annexure B (source 4); live Phase 3 notice (source 3).

The practical consequence is not to defer quality-system work until a future submission date. Version 2 states that documentary proof must be held by manufacturers and distributors/importers. It expressly permits SAHPRA requests during reviews, investigations and vigilance work. A no-fee notification today is not an exemption from quality requirements, and Phase 3 is not a blanket certificate mandate for every amendment.4

Check the certificate against the South African establishment’s name, address and relevant activities. The FAQ allows a global certificate only where the South African establishment is listed; a foreign parent certificate that omits the local establishment does not solve the problem. Use SAHPRA’s current recognised-CAB information rather than assuming that any overseas accreditation mark is sufficient.14

For wholesalers, the current FAQ says an ISO 13485 accreditation certificate need not be submitted; a Site Master File is required, with a quality manual acceptable if aligned to wholesaling activities. The manufacturer/importer timetable should not be relabelled a universal wholesaler deadline. Confirm the current position for the actual activity, especially if the business intends to start importing and therefore change licence type.124

What changes when renewal is approaching?

Submit renewal at least 90 days before expiry. Q&A section 3.2.1 and section 3.1 of the later renewal-process communication, dated 11 June 2025 and posted in July, state that requirement. The live FAQ says renewals submitted less than 90 days before expiry will not be accepted; the later communication’s process flow also shows rejection inside that window. Q&A section 3.2.5 instead contains a conflicting six-week rejection threshold. Do not rely on the six-week wording to plan a late renewal; ask SAHPRA about the required new application and licence position if the 90-day deadline has been missed.126

The renewal communication posted in July says submissions made after expiry will not be accepted and a new application is required. The Q&A cites section 22C(6): manufacturing, wholesaling or distribution requires the relevant licence. A submission receipt alone is not evidence of an extension. This guide does not establish that a timely pending renewal automatically permits continued trading after expiry; obtain confirmation of the licence position before scheduling supply.26

Keep renewal planning and the product launch as separate records. First establish expiry, retention-payment status and renewal submission needs. Then record which requested changes can accompany renewal and which must wait for an amendment. This prevents a supplier’s delivery commitment from being mistaken for evidence that the local licensee can lawfully add the line.

What does the licence leave unanswered?

The establishment licence is an operating permission, not a device-level safety review. Q&A section 3.1.27 makes the distinction explicit in its Certificate of Free Sale discussion: the medical devices have not been assessed for safety and performance by SAHPRA. Do not turn a licence, a listed product or a CFS into a claim of individual device approval.2

SAHPRA’s operational page says device registration is still in development and describes a future Registration Call-Up Plan. Check current product-specific notices before treating that general statement as a complete market-entry answer. The licence worksheet cannot establish a product’s registration, special authorization, import documentation or tender acceptability.35

The same hub states that evidence of a valid establishment licence is required for national and provincial tender eligibility. That is one bidding gate. It does not establish that a specific circumcision device meets a programme’s clinical, age-band or evidence requirements. The separate South African VMMC contract analysis addresses that different procurement decision.3

How does a sterile consumable supplier use the worksheet?

Consider a buyer evaluating the VEMERIX disposable circumcision stapler. The public product record describes a single-use, factory-EO-sterilized device and Chinese NMPA registration. Those identity facts neither assign a South African class nor establish local authorization. Factory EO sterilization alone is also not proof that a buyer has reviewed an ISO 11135 validation package.10

The local partner first identifies whether it will import directly or buy through an existing local licensee. For direct importing, a wholesaler licence does not cover the activity. Next it establishes the device’s South African classification and compares the class with the issued licence. Only then can it decide whether the product addition is a notification, an amendment or part of a new application. Finally it matches its own ISO evidence to the relevant route and date.124

The following is an editorial coordination checklist, not a list of documents guaranteed available from VEMERIX or a substitute for the regulator’s application requirements. Specify the product configuration, document owner and unresolved question before committing to a sample programme, shipment or bid.

RecordLocal licensee checkSupplier requestDecision left open
Activity and licenceLicence number, type, entity, sites, classes and expiry; proposed importing/distribution roleExact legal manufacturer and product identityWhether the local licence covers the proposed activity
Product-list changeExisting approved list, proposed changes and local classification rationaleIntended purpose, models/sizes and current product documentationNotification or amendment; written outcome still required
Quality-system evidenceOwn certificate or documented CAB agreement, site coverage and applicable phaseAsk which manufacturer quality documents can be supplied and under what access conditionsForeign factory evidence does not replace local licensee evidence
Sterile configurationMatch ordered SKU, packaging, storage and receiving requirementsRequest the available sterilization, packaging, shelf-life and release evidence for that configurationDo not infer validation scope from the word sterile
Tender and launchActual bid conditions, required product evidence and filing sequenceAgree document availability, responsible contacts and realistic handoff datesNo licence alone proves clinical acceptance or tender eligibility of the product
Buyer-to-supplier evidence handoff

Source: Editorial buyer checklist informed by sources 1–4 and 10. Product-specific evidence availability and bid conditions require separate confirmation.

Where VEMERIX fits in the document handoff

VEMERIX is the international brand of Weihai Medison Medical Equipment Co., Ltd., positioned as a Minimally Invasive Surgery Total Solution Platform serving urology, vascular surgery and perioperative care.

For a proposed sterile consumable partnership, ask VEMERIX about the available product and supplier documentation. Send the proposed activity, target product and configuration, current licence type, locally established classification, required filing or tender date, and the evidence gaps in the checklist. Agree what can be supplied before relying on it. This article establishes no South African licence, local classification, tender approval or filing service for VEMERIX.

Frequently asked questions

Does a no-fee notification let us launch immediately?
No automatic launch permission follows from the fee category. The Q&A says notifications are reviewed and approved or rejected, with a written outcome. Keep that outcome alongside the approved product list and separately check other applicable product and transaction requirements.12

Must the old licence be withdrawn when changing licence type?
A new licence application is required. Section 3.1.18 says that after approval the company may request withdrawal of the initial licence. Section 3.1.19 discourages redundant manufacturer and distributor licences at the same site and notes retention fees apply to both if retained. Withdrawal is not described as automatic.2

Can we renew while still obtaining ISO certification?
The written version 2 communication provides for documentary proof of an agreement with a SAHPRA-recognised CAB while certification is in process, followed by submission of the acquired certificate. This is a documented route, not a guarantee that an unsupported application or self-declaration will be accepted.46

Which details need rechecking before submission?
Recheck the current application form, Gazette fees, licence particulars, device class, written change outcome, renewal position and any later ISO, outsourcing or product-registration communication. The worksheet is useful because it keeps these decisions visible; it does not replace SAHPRA confirmation where the facts or current instructions are uncertain.125

Sources

  1. SAHPRA — FAQs: Medical Devices Licencing. Current licence-type, notification, amendment, renewal and quality-system guidance; accessed 2 November 2026.
  2. SAHPRA — Guideline on Questions and Answers: Licensing of Medical Device Establishments, version 4, 21 May 2025. Sections 3.1.3, 3.1.10–3.1.21, 3.1.27, 3.2 and 3.3; accessed 2 November 2026.
  3. SAHPRA — Medical Devices operational page. Licence activities, Class A exemption, tender eligibility, product-registration boundary and Phase 3 notice; accessed 2 November 2026.
  4. SAHPRA — ISO 13485 Certificate as a Prerequisite for the Approval of a Medical Device Establishment Licence, MD01-2025/2026 version 2, signed 18 September 2025. Phases 2–5 and Annexure B; accessed 2 November 2026.
  5. SAHPRA — Medical Devices and In Vitro Diagnostics Communication to Industry index. Check for later communications before filing; accessed 2 November 2026.
  6. SAHPRA — Medical Device Establishment Licence Renewal Process, MD06-2025/26, dated 11 June 2025 and posted 17 July 2025. Sections 2–3 and Annexure 1, including the 90-day submission rule; reviewed 2 November 2026.
  7. SAHPRA — Notification of an Update to the Product List(s) of a Medical Device Establishment Licence, MD092025/26, 27 January 2026. Official document landing page; accessed 2 November 2026.
  8. SAHPRA — Amendment of a Medical Device Establishment Licence, MD102025/26, 27 January 2026. Official document landing page; accessed 2 November 2026.
  9. SAHPRA — Licensing Requirements for Outsourced or Contracted Activities for Medical Device Establishments, MD02-2026/27, 10 April 2026. Official document landing page; accessed 2 November 2026.
  10. VEMERIX — Disposable Circumcision Stapler. First-party description of single-use design, factory EO sterilization and Chinese NMPA registration; reviewed 2 November 2026. This source establishes no South African classification or authorization.

Talk to VEMERIX

VEMERIX is the international brand of Weihai Medison Medical Equipment Co., Ltd., positioned as a Minimally Invasive Surgery Total Solution Platform serving urology, vascular surgery and perioperative care.